Canadian medical biotechnology co-innovation mission to the Eureka Global Innovation Summit and Swiss Biotech Day in Switzerland

To participate in this initiative, Canadian participants should meet the following requirements:

• be an incorporated, profit-oriented small or medium-sized enterprise (SME) in Canada (defined as having 500 or fewer full-time equivalent employees)
• have been in operation for a minimum of 12 months prior to the Canadian registration deadline specified above
• have a minimum of 5 full-time equivalent (FTE) employees located in Canada (on the company payroll and issued a T4), excluding contract employees, by the Canadian registration deadline
• pursue growth and profit by developing and commercializing innovative, technology-driven new or improved products, services, or processes in Canada
• have a differentiated and protectable technology with commercial potential in global markets
• have the financial capacity (working capital, sales revenue, investment, etc.) and the operational capacity (personnel, expertise, resources, etc.) to undertake an international multi-year R&D collaboration while maintaining regular operations, and to subsequently commercialize the results
• be committed to significant growth through international market expansion

Preference may be given to SME applicants who meet the criteria below:

• have a minimum of 10 full‑time equivalent (FTE) employees located in Canada (on the company payroll and issued a T4), excluding contract employees
• have commercialized 1 or more products internationally
• have more than $500,000 CAD in annual sales revenue